D-112
NDC 58264-0118, Lachesis Muta venom, Silicon dioxide, Sodium chloride, Ranunculus bulbosus, Aconitum napellus, Activated charcoal, Nitroglycerin, Oyster shell calcium carbonate, crude, Anemone pratensis, Plantago major, arsenic trioxide, and Magnesium phosphate, dibasic trihydrate, solution, from DNA Labs, Inc..
- Product NDC
- 58264-0118
- Status
- Listed
- Labeler
- DNA Labs, Inc.
- Dosage form
- SOLUTION
- Route
- SUBLINGUAL
- Product type
- HUMAN OTC DRUG
- Marketing category
- UNAPPROVED HOMEOPATHIC
- Application
- —
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/58264-0118 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- LACHESIS MUTA VENOM12 [hp_X]/mL
- SILICON DIOXIDE8 [hp_X]/mL
- SODIUM CHLORIDE4 [hp_X]/mL
- RANUNCULUS BULBOSUS4 [hp_X]/mL
- ACONITUM NAPELLUS4 [hp_X]/mL
- ACTIVATED CHARCOAL8 [hp_X]/mL
- NITROGLYCERIN6 [hp_X]/mL
- OYSTER SHELL CALCIUM CARBONATE, CRUDE8 [hp_X]/mL
- ANEMONE PRATENSIS4 [hp_X]/mL
- PLANTAGO MAJOR4 [hp_X]/mL
- ARSENIC TRIOXIDE6 [hp_X]/mL
- MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE4 [hp_X]/mL
Pharmacologic classes
Calculi Dissolution Agent [EPC]; Increased Large Intestinal Motility [PE]; Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]; Inhibition Small Intestine Fluid/Electrolyte Absorption [PE]; Magnesium Ion Exchange Activity [MoA]; Nitrate Vasodilator [EPC]; Nitrates [CS]; Osmotic Activity [MoA]; Osmotic Laxative [EPC]; Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]; Vasodilation [PE]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 58264-0118-1 | 58264011801 | 29.57 mL in 1 BOTTLE, GLASS (58264-0118-1) |
Linked data
RxNorm, label and prices
RxNorm concepts
RxNorm links no concept to this product's packages.
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 58264-0118 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/58264-0118 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 58264-0118. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.